Ramazan Zor Kürşad, Sarı İsmail, Yıldırım Biçer Gamze, Güntürk İnayet, Küçük Erkut, Erşan Serpil, Seydel Gönül Şeyda
Niğde Ömer Halisdemir University School of Medicine Department of Ophthalmology, Bor Yolu, Niğde, Turkey.
Niğde Ömer Halisdemir University School of Medicine Department of Biochemistry, Bor Yolu, Niğde, Turkey.
J Med Biochem. 2022 Jul 29;41(3):275-281. doi: 10.5937/jomb0-32189.
This study aims to compare serum HMGB-1, 3-nitrotyrosine (3-NT), TAS, TOS, and OSI levels in Wettype Age-Related Macular Degeneration (wAMD) patients and healthy controls to determine the correlation of these parameters with each other.
Thirty patients with Wet-type Age-Related Macular Degeneration (wAMD) and 27 healthy adults, as controls were enrolled in the study. We determined the TAS and TOS levels in serum samples of both groups using commercial kits on a microplate reader. Serum HMGB-1 and 3-NT levels were measured with the enzyme-linked immunosorbent assay method.
HMGB-1 levels were significantly higher in the patient group (137.51 pg/mL, p=0.001), while there was no difference between the two groups in serum 3-NT levels (p=0.428). A statistically significant difference found in the levels of TOS and OSI (p=0.001 and p=0.045, respectively) between the patients and controls, however, no significant difference was observed between the groups in terms of TAS levels (p=0.228).
Oxidative stress and HMGB-1 levels were increased in wAMD patients and enhanced oxidative stress may be associated with increased tissue necrosis and inflammation. Thus administration of antioxidant treatment in addition to routine therapy should be considered in wAMD.
本研究旨在比较湿性年龄相关性黄斑变性(wAMD)患者和健康对照者血清中高迁移率族蛋白B1(HMGB-1)、3-硝基酪氨酸(3-NT)、总抗氧化状态(TAS)、总氧化状态(TOS)和氧化应激指数(OSI)水平,以确定这些参数之间的相关性。
本研究纳入了30例湿性年龄相关性黄斑变性(wAMD)患者和27例健康成年人作为对照。我们使用酶标仪上的商业试剂盒测定了两组血清样本中的TAS和TOS水平。采用酶联免疫吸附测定法测量血清HMGB-1和3-NT水平。
患者组的HMGB-1水平显著更高(137.51 pg/mL,p = 0.001),而两组血清3-NT水平无差异(p = 0.428)。患者和对照组之间在TOS和OSI水平上发现有统计学显著差异(分别为p = 0.001和p = 0.045),然而,两组之间在TAS水平方面未观察到显著差异(p = 0.228)。
wAMD患者的氧化应激和HMGB-1水平升高,氧化应激增强可能与组织坏死和炎症增加有关。因此,在wAMD中除常规治疗外应考虑给予抗氧化治疗。